Found: 10
Select item for more details and to access through your institution.
BiSpec Pairwise AI: guiding the selection of bispecific antibody target combinations with pairwise learning and GPT augmentation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 5, p. 1, doi. 10.1007/s00432-024-05740-3
- By:
- Publication type:
- Article
A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 526, doi. 10.3390/vaccines11030526
- By:
- Publication type:
- Article
A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 702, doi. 10.3390/vaccines10050702
- By:
- Publication type:
- Article
Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection.
- Published in:
- Scientific Reports, 2017, p. 45552, doi. 10.1038/srep45552
- By:
- Publication type:
- Article
A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 Omicron subvariants and other variants.
- Published in:
- SCIENCE CHINA Life Sciences, 2023, v. 66, n. 8, p. 1818, doi. 10.1007/s11427-022-2207-7
- By:
- Publication type:
- Article
An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2.
- Published in:
- SCIENCE CHINA Life Sciences, 2023, v. 66, n. 1, p. 165, doi. 10.1007/s11427-022-2166-y
- By:
- Publication type:
- Article
Mutation N856K in spike reduces fusogenicity and infectivity of Omicron BA.1.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Novel hKDR mouse model depicts the antiangiogenesis and apoptosis‐promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2.
- Published in:
- Cancer Science, 2023, v. 114, n. 1, p. 115, doi. 10.1111/cas.15594
- By:
- Publication type:
- Article
Rational Development of a Polysaccharide–Protein‐Conjugated Nanoparticle Vaccine Against SARS‐CoV‐2 Variants and Streptococcus pneumoniae (Adv. Mater. 21/2022).
- Published in:
- Advanced Materials, 2022, v. 34, n. 21, p. 1, doi. 10.1002/adma.202270160
- By:
- Publication type:
- Article
Rational Development of a Polysaccharide–Protein‐Conjugated Nanoparticle Vaccine Against SARS‐CoV‐2 Variants and Streptococcus pneumoniae.
- Published in:
- Advanced Materials, 2022, v. 34, n. 21, p. 1, doi. 10.1002/adma.202200443
- By:
- Publication type:
- Article